2023
Nov. 15: Congratulations to graduate student, Madeline (Maddie) Balzarini, for completing her Ph.D., with the Skaggs Graduate School of Chemical and Biological Sciences.
Oct. 1: Kodadek Laboratory awarded an NIH Transformative RO1 grant to develop Ubiquitin-independent degraders.
The NIH/NCI has announced that the Kodadek Laboratory will receive a five year, $4.1 M grant to develop drug candidates that catalyze the destruction of target proteins by recruiting them directly to the proteasome. This award is from the Office of the Director’s program to fund “exceptionally innovative and impactful science”.